Preparation of 6-substituted quinoxaline JSP-1 inhibitors by microwave accelerated nucleophilic substitution

Molecules

Volumn 11, Issue 12, 2006, Pages 988-999

  Zhang, Li ^a   Qiu, Beiying ^b   Li, Xin ^a   Wang, Xin ^a   Li, Jingya ^b   Zhang, Yongliang ^a   Liu, Jian ^a   Li, Jia ^b   Shen, Jingkang ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b National Center for Drug Screening   (China)

Author keywords

6 substituted quinoxalines; JSP 1; Microwave irradiation; Nucleophilic substitution

Indexed keywords

AMINE; DUAL SPECIFICITY PHOSPHATASE; DUSP22 PROTEIN, HUMAN; ENZYME INHIBITOR; HETEROCYCLIC COMPOUND; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; DRUG ANTAGONISM; HUMAN; MICROWAVE RADIATION; SYNTHESIS;

AMINES; DUAL-SPECIFICITY PHOSPHATASES; ENZYME INHIBITORS; HETEROCYCLIC COMPOUNDS; HUMANS; MICROWAVES; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; MODELS, CHEMICAL; QUINOXALINES;

EID: 33846033567     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/11120988     Document Type: Article

References (36)

1. N receptor antagonists: Amino acid derivatives. J. Med. Chem. 1999, 42, 2266-2271.
2. Auberson, Y. P.; Bischoff, S.; Moretti, R.; Schmutz, M.; Veenstra, S. J. 5-Aminomethylquinoxaline-2, 3-diones. Part I: A novel class of AMPA receptor antagonists. Bioorg. Med. Chem. Lett. 1998, 8, 65-70.
3. Auberson, Y. P.; Acklin, P.; Allgeier, H.; Biollaz, M.; Bischoff, S.; Ofner, S.; Veenstra, S. J. 5-Aminomethylquinoxaline-2,3-diones. Part II: N-aryl derivatives as novel NMDA/glycine and AMPA antagonists. Bioorg. Med. Chem. Lett. 1998, 8, 71-74.
4. Kim, K. S.; Qian, L. G.; Dickinson, K. E. J.; Delaney, C. L.; Bird, J. E.; Waldron, T. L.; Moreland, S. Synthesis, biological properties, and structure-activity-relationships of quinoxaline angiotensin-II receptor antagonists. Bioorg. Med. Chem. Lett. 1993, 3, 2667-2670.
5. Kim, K. S.; Qian, L. G.; Bird, J. E.; Dickinson, K. E. J.; Moreland, S.; Schaeffer, T. R.; Waldron, T. L.; Delaney, C. L.; Weller, H. N.; Miller, A. V. Quinoxaline N-Oxide containing potent angiotensin-II receptor antagonists - synthesis, biological properties, and structure-activity-relationships. J. Med. Chem. 1993, 36, 2335-2342.
6. Perez-Melero, C.; Maya, A. B. S.; del Rey, B.; Pelaez, R.; Caballero, E.; Medarde, M. A new family of quinoline and quinoxaline analogues of combretastatins. Bioorg. Med. Chem. Lett. 2004, 14, 3771-3774.
7. Piras, S.; Loriga, M.; Paglietti, G. Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-{[4-(substituted 2-quinoxalinyloxy) phenyl] acetyl} glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity. Il Farmaco, 2004, 59, 185-194.
8. Corona, P.; Vitale, G.; Loriga, M.; Paglietti G. Quinoxaline chemistry. Part 13: 3-carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activity. Il Farmaco, 2000, 55, 77-86.
9. Monge, A.; Palop, J. A.; de Cerain A. L.; Senador, V.; Martinez-Crespo, F. J.; Sainz, Y.; Narro, S.; Garcia, E.; de Miguel, C.; Gonzalez, M.; Hamilton, E.; Barker, A. J.; Clarke, E. D.; Greenhow, D. T. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides. J. Med. Chem. 1995, 38, 1786-1792.
10. Carta, A.; Loriga, M.; Zanetti, S.; Sechi, L. A. Quinoxalin-2-ones: Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl- and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety. Il Farmaco 2003, 58, 1251-1255.
11. Hui, X.; Desrivot, J.; Bories, C.; Loiseau, P. M.; Franck, X.; Hocquemiller, R.; Figadere, B. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines. Bioorg. Med. Chem. Lett. 2006, 16, 815-820.
12. Alamino, R. J. Thiocyanatoquinoxaline compounds with immunomodulating activity. U.S. Patent 4,540,693, 1985; [Chem. Abstr. 1986, 104, 88601].
13. Li, J.; Chen, J.; Zhang, L.; Wang, F.; Gui, C.; Zhang, L.; Qin, Y.; Xu, Q.; Liu, H.; Nan, F.; Shen, J.; Bai, D.; Chen, K.; Shen, X.; Jiang, H. One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation. Bioorg. Med. Chem. 2006, 14, 5527-5534.
14. Shen, Y.; Luche, R.; Wei, B.; Gordon, M. L; Diltz, C. D.; Tonks, N. K. Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1. Proc. Natl. Acad. Sci U.S.A, 2001, 98, 13613-13618.
15. Alonso, A.; Merlo, J. J.; Na, S. Q.; Kholod, N.; Jaroszewski, L.; Kharitonenkov, A.; Williams, S.; Godzik, A.; Posada, J. D.; Mustelin, T. Inhibition of T Cell Antigen Receptor Signaling by VHR-related MKPX (VHX), a New Dual Specificity Phosphatase Related to VH1 Related (VHR). J. Biol. Chem. 2002, 277, 5524-5528.
16. Chen, A. J.; Zhou, G. S.; Juan, T.; Colicos, S. M.; Cannon, J. P.; Cabriera-Hansen, M.; Meyer, C. F.; Jurecic, R.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Fletcher, F.; Tan, T. H.; Belmont, J. W. The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway. J. Biol. Chem. 2002, 277, 36592-36601.
17. Alonso, A.; Rojas, A.; Godzik, A.; Mustelin, T. The dual-specific protein tyrosine phosphatase family. Top. Curr. Genetics 2004, 5, 333-358.
18. Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103, 239-252.
19. Manning, A. M.; Davis, R. J. Targeting JNK for Therapeutic Benefit: from JUNK to gold? Nat. Rev. Drug Disc. 2003, 2, 554-565.
20. Zhao, Z. J.; Wisnoski, D. D.; Wolkenberg, S. E.; Leister, W. H.; Wang, Y.; Lindsley, C. W. General microwave-assisted protocols for the expedient synthesis of quinoxalines and heterocyclic pyrazines. Tetrahderon Lett. 2004, 45, 4873-4876.
21. Abdel-Jalil, R. J.; Al-Qawasmeh, R. A.; Voelter, W.; Heeg, P.; El-Abadelah, M. M.; Sabri, S. S. Synthesis and properties of some 2,3-disubstituted 6-fluoro-7-(4-methyl-1-piperazinyl)quinoxalines. J. Heterocycl. Chem. 2000, 37, 1273-1275.
22. Charushin, V. N.; Mokrushina, G. A.; Tkachev, A. V. Nucleophilic substitutions in 6,7-difluoroquinoxalines. J. Fluorine Chem. 2001, 107, 71-80.
23. Kotovskaya, S. K.; Romanova, S. A.; Charushin, V. N.; Chupakhin, O. N. Fluorine-containing heterocycles: VII. Nucleophilic substitution in 6,7-difluoroquinoxalines. Russ. J. Org. Chem. 2002, 38, 1046-1052.
24. Takano, Y.; Shiga, F.; Asano, J.; Ando, N.; Uchiki, H.; Anraku, T. Synthesis and AMPA receptor antagonistic activity of a novel class of quinoxalinecarboxylic acid with a substituted phenyl group at the C-7 position. Bioorg. Med. Chem. Lett. 2003, 13, 3521-3526.
25. Takano, Y.; Shiga, F.; Asano, J.; Ando, N.; Uchiki, H.; Fukuchi, K.; Anraku, T. Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position. Bioorg. Med. Chem. 2005, 13, 5841-5863.
26. (a) Olsson, K.; Grivas, S. New synthetic routes to the potent mutagen 3,7,8-Trimethyl-3H-imidazo[4,5-f]quinoxalin-2-amine. Acta Chem. Scand. Ser.B. 1986, 40, 486-492.
27. 14C-labelled analogue. Acta Chem. Scand. Ser.B. 1985, 39, 31-34.
28. Kappe, C. O. Controlled microwave heating in modern organic synthesis. Angew. Chem. Int. 2004, 43, 6250-6284.
29. Ersmark, K.; Larhed, M.; Wannberg, J. Microwave-enhanced medicinal chemistry: A high-speed opportunity for convenient preparation of protease inhibitors. Curr. Opin. Drug Discov. Dev. 2004, 7, 417-427.
30. Mavandadi, F.; Lidstrom, P. Microwave - Assisted chemistry in drug discovery. Curr. Top. Med. Chem. 2004, 4, 773-792.
31. Lidstrom, P.; Tierney, J.; Wathey, B.; Westman, J. Microwave assisted organic synthesis - a review. Tetrahedron 2001, 57, 9225-9283.
32. Xu, Y.; Guo, Q. X. Syntheses of heterocyclic compounds under microwave irradiation. Heterocycles. 2004, 63, 903-974.
33. Wilson, N. S.; Roth, G. P. Recent trends in microwave-assisted synthesis. Curr. Opin. Drug Discov. Dev. 2002, 5, 620-629.
34. Ding, D. R.; Li, X.; Wang, X.; Du, Y. L.; Shen, J. K. Microwave-assisted rapid and straightforward synthesis of 2-aryl-4-quinolones from acylated 2′-aminoacetopheinones. Tetrahderon Lett. 2006, 47, 6997-6999.
35. Ahmad, A.; Dunbar, L. J.; Green, I. G.; Harvey, I. W.; Shepherd, T.; Smith, D. M.; Wong, R. K. C. Polyaza heterocycles. Part 2. Nucleophilic substitution of halogens in halogenoquinoxalino[2,3-c]cinnolines. J. Chem. Soc., Perkin Trans. 1 1994, 2751-2758.
36. Cutshall, N. S.; O'Day, C.; Prezhdo, M. Rhodanine derivatives as inhibitors of JSP-1. Bioorg. Med. Chem. Lett. 2005, 15, 3374-3379.